Systemic management of cutaneous bacterial infections.

[1]  Bailey Em,et al.  Enoxacin--a new fluoroquinolone. , 1989, The Medical letter on drugs and therapeutics.

[2]  L. Parish,et al.  Systemic antimicrobial therapy in skin and skin structure infections: comparison of temafloxacin and ciprofloxacin. , 1991, The American journal of medicine.

[3]  K. Neldner.  Double-blind randomized study of oral temafloxacin and cefadroxil in patients with mild to moderately severe bacterial skin infections. , 1991, The American journal of medicine.

[4]  D. Hooper,et al.  Emerging resistance to fluoroquinolones in staphylococci: an alert. , 1991, Annals of internal medicine.

[5]  H. Gadebusch,et al.  Norfloxacin, the first of a new class of fluoroquinolone antimicrobials, revisited. , 1991, International journal of antimicrobial agents.

[6]  J Ferguson,et al.  Ciprofloxacin‐induced photosensitivity: in vitro and in vivo studies , 1990, The British journal of dermatology.

[7]  W. Awni,et al.  Steady-state pharmacokinetics of fleroxacin in patients with skin and skin structure infections , 1990, Antimicrobial Agents and Chemotherapy.

[8]  D. Hooper,et al.  Fluoroquinolone antimicrobial agents. , 1991, Clinical microbiology reviews.

[9]  E. McGoodwin,et al.  Anaphylactoid reactions reported after treatment with ciprofloxacin. , 1989, Annals of internal medicine.

[10]  L. Parish,et al.  The Infected Decubitus Ulcer , 1989, International journal of dermatology.

[11]  L. Gentry,et al.  Intravenous/oral ciprofloxacin versus intravenous ceftazidime in the treatment of serious gram-negative infections of the skin and skin structure. , 1989, The American journal of medicine.

[12]  W. Bowie,et al.  Adverse reactions in a dose-ranging study with a new long-acting fluoroquinolone, fleroxacin , 1989, Antimicrobial Agents and Chemotherapy.

[13]  K. Nye,et al.  The in-vitro activity, pharmacokinetics and tissue penetration of temafloxacin. , 1989, The Journal of antimicrobial chemotherapy.

[14]  P. Colletti,et al.  Pulmonary Kaposi's sarcoma: clinical findings and results of therapy. , 1989, The American journal of medicine.

[15]  G. Pankey,et al.  Treatment of Pseudomonas aeruginosa auricular perichondritis with oral ciprofloxacin. , 1989, The Journal of dermatologic surgery and oncology.

[16]  E. A. Abd El-Meguid,et al.  Evaluation of the release and efficacy of two new antibacterial agents from different ointment bases. , 1989, Pharmazie.

[17]  H. Thadepalli,et al.  Ciprofloxacin versus ceftazidime in skin and soft tissue infections. , 1989, Journal of chemotherapy.

[18]  I. Foresti,et al.  Rufloxacin (MF-934): in vitro and in vivo antibacterial activity. , 1989, Drugs under experimental and clinical research.

[19]  G. Pankey.  Review of Tissue Penetration and Clinical Efficacy of Enoxacin in Skin and Skin Structure Infections and in Osteomyelitis , 1989, Clinical pharmacokinetics.

[20]  J. Monk,et al.  Enoxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. , 1988, Drugs.

[21]  J. Witkowski,et al.  Treatment of Cutaneous Infections Worldwide Experience with Ciprofloxacin , 1988, International journal of dermatology.

[22]  A. Heyd,et al.  A Survey of Clinical Experience with Ciprofloxacin, a New Quinolone Antimicrobial , 1988, Journal of clinical pharmacology.

[23]  H. Gallis,et al.  Ofloxacin: Its Pharmacology, Pharmacokinetics, and Potential for Clinical Application , 1988, Pharmacotherapy.

[24]  R. R. Bower,et al.  Comparative antibacterial activities of temafloxacin hydrochloride (A-62254) and two reference fluoroquinolones , 1987, Antimicrobial Agents and Chemotherapy.

[25]  D. Cocchetto,et al.  Cefuroxime Axetil in the Treatment of Cutaneous Infections , 1987, International journal of dermatology.

[26]  C. Licitra,et al.  Clinical efficacy and levels of ciprofloxacin in tissue in patients with soft tissue infection , 1987, Antimicrobial Agents and Chemotherapy.

[27]  E. Rodriguez-Noriega,et al.  Double-blind comparison of ciprofloxacin with cefotaxime in the treatment of skin and skin structure infections. , 1987, American Journal of Medicine.

[28]  L. Parish,et al.  Systemic treatment of cutaneous infections. A comparative study of ciprofloxacin and cefotaxime. , 1987, The American journal of medicine.

[29]  L. Parish,et al.  The Quinolones and Dermatologic Practice , 1986, International journal of dermatology.

[30]  L. Parish,et al.  Cephalosporins in Cutaneous Infections , 1986, International journal of dermatology.

[31]  R. Baran,et al.  Photoonycholysis induced by the fluoroquinolones pefloxacine and ofloxacine. Report on 2 cases. , 1986, Dermatologica.

[32]  H. Mensing.  [Results of treatment of bacterial inflammation of the skin with enoxacin]. , 1986, Infection.

[33]  Parish Lc,et al.  Treatment of skin and skin structure infections: a comparative study of Augmentin and cefaclor. , 1984 .

[34]  Parish Lc,et al.  Ceforanide compared with cefazolin in skin and soft tissue infections. , 1984 .

[35]  Uriburu Jv,et al.  Ceftizoxime treatment of cutaneous and subcutaneous tissue infections. , 1984 .

[36]  C. W. Linder,et al.  The child with impaired consciousness. , 1982, Postgraduate medicine.

[37]  L. Parish,et al.  Bacterial skin infections: management of common streptococcal and stapylococcal lesions. , 1982, Postgraduate medicine.

[38]  L. Goldfrank,et al.  Bacterial food poisoning: what to do if prevention fails. , 1982, Postgraduate medicine.